Caseware UK (AP4) 2023.0.135 2023.0.135 2023-12-312023-12-31No description of principal activityfalsetrue02023-01-01true0true 06778682 2022-12-31 06778682 2023-01-01 2023-12-31 06778682 2022-01-01 2022-12-31 06778682 2023-12-31 06778682 c:Director1 2023-01-01 2023-12-31 06778682 d:CurrentFinancialInstruments 2023-12-31 06778682 d:CurrentFinancialInstruments 2022-12-31 06778682 c:EntityHasNeverTraded 2023-01-01 2023-12-31 06778682 c:FRS102 2023-01-01 2023-12-31 06778682 c:AuditExempt-NoAccountantsReport 2023-01-01 2023-12-31 06778682 c:FullAccounts 2023-01-01 2023-12-31 06778682 c:PrivateLimitedCompanyLtd 2023-01-01 2023-12-31 06778682 e:PoundSterling 2023-01-01 2023-12-31 iso4217:GBP xbrli:pure

Registered number: 06778682










BELGRAVE BLOODSTOCK LIMITED








UNAUDITED

FINANCIAL STATEMENTS

INFORMATION FOR FILING WITH THE REGISTRAR

FOR THE YEAR ENDED 31 DECEMBER 2023

 
BELGRAVE BLOODSTOCK LIMITED
REGISTERED NUMBER: 06778682

BALANCE SHEET
AS AT 31 DECEMBER 2023

2023
2022
Note
£
£

  

Fixed assets
  

Current assets
  

Debtors: amounts falling due within one year
 3 
2
2

  
2
2

Total assets less current liabilities
  
 
 
2
 
 
2

  

  

  

Net assets excluding pension asset
  
2
2

Net assets
  
2
2


Capital and reserves
  

Called up share capital 
  
2
2

  
2
2


For the year ended 31 December 2023 the Company was entitled to exemption from audit under section 480 of the Companies Act 2006.

Members have not required the Company to obtain an audit for the year in question in accordance with section 476 of the Companies Act 2006.

The director acknowledges his responsibilities for complying with the requirements of the Companies Act 2006 with respect to accounting records and the preparation of financial statements.

The financial statements have been prepared in accordance with the provisions applicable to companies subject to the small companies regime and in accordance with the provisions of FRS 102 Section 1A - small entities.

The financial statements have been delivered in accordance with the provisions applicable to companies subject to the small companies regime.

The Company has opted not to file the profit and loss account in accordance with provisions applicable to companies subject to the small companies' regime.

The financial statements were approved and authorised for issue by the board and were signed on its behalf on: 




................................................
N Ryder
Director

Date: 12 September 2024

Page 1

 
BELGRAVE BLOODSTOCK LIMITED
 

 
NOTES TO THE FINANCIAL STATEMENTS
FOR THE YEAR ENDED 31 DECEMBER 2023

1.


General information

Belgrave Bloodstock is a private company limited by share capital and incorporated in England and Wales. 
The address of the registered office is 2 Communications Road, Greenham Business Park, Newbury, Berkshire RG19 6AB.
The company is dormant and has not traded during the year or the preceding financial year.

2.Accounting policies

 
2.1

Basis of preparation of financial statements

The financial statements have been prepared under the historical cost convention unless otherwise specified within these accounting policies and in accordance with FRS 102 'The Financial Reporting Standard applicable in the UK and the Republic of Ireland' and the requirements of the Companies Act 2006. The disclosure requirements of Section 1A of FRS 102 have been applied other than where additional disclosure is required to show a true and fair view.


3.


Debtors

2023
2022
£
£


Called up share capital not paid
2
2

2
2


Page 2